KURA ONCOLOGY, INC.

Profile

Company Names

KURA ONCOLOGY, INC.

Addresses

12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA 92130

11119 N. TORREY PINES ROAD, STE 125, LA JOLLA, CA 92037

Phone Numbers

(858) 500-8800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$241,692,487.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-01-26 
$150,000,808.00 
$150,000,808.00 
$0.00 
Equity 
1
2015-03-06 
$91,691,679.00 
$91,691,679.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TERESA 
 
BAIR 
EXECUTIVE OFFICER
BIRCHBIOMED INC.   |  KURA ONCOLOGY, INC.
HELEN 
 
COLLINS 
DIRECTOR
KURA ONCOLOGY, INC.   |  ENLIVEN THERAPEUTICS, INC.
STEPHEN 
 
DALE 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.   |  SYNCROMUNE, INC.
KATHLEEN 
 
FORD 
EXECUTIVE OFFICER
CASTERS HOLDINGS INC   |  KURA ONCOLOGY, INC.
ANTONIO 
 
GUALBERTO 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  SURGE THERAPEUTICS, INC.
FAHEEM 
 
HASNAIN 
DIRECTOR
SENTE INC   |  AMBIT BIOSCIENCES CORP   |  RECEPTOS, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  TOCAGEN INC   |  WINDSOR BOYS RACING, LLC   |  GOSSAMER BIO, INC.   |  KURA ONCOLOGY, INC.
HEIDI 
 
HENSON 
EXECUTIVE OFFICER
ARAXES PHARMA, LLC   |  KURA ONCOLOGY, INC.   |  KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  PARDES BIOSCIENCES, INC   |  PEPGEN INC.   |  PERSPECTIVE THERAPEUTICS, INC.
YI 
 
LIU 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  KUMQUAT BIOSCIENCES INC   |  CLASS OVER INC. / DE
THOMAS 
 
MALLEY 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  PLAZA AMISTAD ASSOCIATES, L.P.   |  PLAZA AMISTAD ASSOCIATES II, L.P.   |  CAMINO GONZALEZ ASSOCIATES LP   |  AZAHAR PLACE ASSOCIATES, L.P.   |  OVASCIENCE, INC.   |  KURA ONCOLOGY, INC.
ANNETTE 
 
NORTH 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.
DIANE 
 
PARKS 
DIRECTOR
TRISALUS LIFE SCIENCES, INC.   |  KURA ONCOLOGY, INC.   |  CELULARITY INC
BRIAN 
 
POWL 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.
PINGDA 
 
REN 
EXECUTIVE OFFICER
KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  KUMQUAT BIOSCIENCES INC
CAROL 
 
SCHAFER 
DIRECTOR
KURA ONCOLOGY, INC.
MARY 
 
SZELA 
DIRECTOR
SUNEVA MEDICAL INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  KURA ONCOLOGY, INC.   |  TRISALUS LIFE SCIENCES, INC.
TROY 
 
WILSON 
EXECUTIVE OFFICER, DIRECTOR
INTELLIKINE, INC.   |  CENTROSE LLC   |  ARAXES PHARMA, LLC   |  AVIDITY NANOMEDICINES LLC   |  ZOSANO PHARMA CORP   |  KURA ONCOLOGY, INC.   |  KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  ABINTUS BIO, INC.   |  MONTARA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-02-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-01-26 
2015-03-19
D
Link
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
DECLINE TO DISCLOSE 
Equity 
2015-03-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011